# Study To Estimate The Time Course Of PF-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers

> **NCT00977015** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Treatment A
- **DRUG:** Treatment B

## Key facts

- **NCT ID:** NCT00977015
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2010-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00977015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00977015, "Study To Estimate The Time Course Of PF-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00977015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*